¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"optic pathway"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® optic nerve ÇÑ±Û ½Ã°¢½Å°æ
¼³¸í   
  ½Ã°¢À» ÀÎÁöÇϴ ½Å°æ. ÀÌ ½Å°æÀº ´ÜÁö °¨°¢½Å°æÀ¸·Î¼­¸¸ ÀÛ¿ëÇÑ´Ù. µû¶ó¼­ ¾î¶² »ç¹°À» µû¶ó ´«À» ¿òÁ÷ÀÏ ¼ö Àִ °ÍÀº ÀÌ ½Ã°¢½Å°æ°ú´Â ¹«°üÇÏ´Ù(À̰ÍÀº ´«µ¹¸²½Å°æ(oculomotor nerve)¿¡ ÀÇÇØ °¡´ÉÇÏ´Ù). ¶ÇÇÑ ½Ã°¢½Å°æÀº °íÀ§ÁßÃ߽Űæ°èÀΠ³ú¿¡¼­ Á÷Á¢ ºÐÁöÇϹǷΠ¼Õ»ó½Ã Àç»ýÀº ºÒ°¡´ÉÇϸç, ÀÌ¿¡ ´ëÇÑ Ä¡·á¹ýÀº ¾ø´Ù.
¿µ¹® optic disk ÇÑ±Û ½Ã½Å°æÀ¯µÎ
¼³¸í   
  ¸Á¸·ÀÇ ±¸Á¶¸¦ Á÷»ó°Ë¾È°æ(¸Á¸·À» º¸±â À§ÇØ °í¾ÈµÈ °Ë»ç±â±¸)À¸·Î º¸¸é ´ÙÀ½°ú °°´Ù.
  
  ¸Á¸·¿¡ Ç÷¾×À» °ø±ÞÇϴ ¸Á¸·µ¿¸Æ(retinal artery)°ú, ´Ù½Ã Ç÷¾×À» È¸¼öÇϴ ¸Á¸·Á¤¸Æ(retinal vein)Àº ´Ù°°ÀÌ ½Ã°¢½Å°æ(optic nerve)°ú ÇÔ²² ½Ã°¢½Å°æ±¸¸Û(optic foramen)À» ÅëÇØ ¸Á¸·±îÁö À̸£°Ô µÈ´Ù. Áï, À̵頸Á¸· µ¿, Á¤¸ÆÀº ½Ã°¢½Å°æ¼Ó¿¡ ³¢¿öÁø Ã¤ ¸Á¸·±îÁö À̸£°Ô µÈ´Ù. µû¶ó¼­ À̵頸Á¸· µ¿, Á¤¸Æ ÁÖÀ§¿¡ Á¸ÀçÇϴ ½Ã°¢½Å°æÀ¯µÎ´Â ¹Ù·Î ½Ã°¢½Å°æÀÇ ÀϺκÐÀ» ¸»ÇÑ´Ù. ºûÀÇ ÀÚ±ØÀ» ÀÌÇØÇÒ ¼ö Àִ ½Åȣü°è·Î ¹Ù²Ù´Â ½Ã°¢¼¼Æ÷´Â ¹Þ¾ÆµéÀΠÀÚ±ØÀ» ½Ã°¢½Å°æ¿¡¼­ ºÐÁöÇÑ ¼ö¸¹Àº ½Å°æÀý¼¼Æ÷(ganglion cell: ½Å°æÀü´ÞÀ» ¸ð¾Æ¼­ º¸´Ù Å« Àü´Þ´ÜÀ§·Î ÀüÇØÁִ ¿ªÇÒÀ» Çϸç, ¸Á¸·³»¿¡ À§Ä¡ÇÑ´Ù)·Î Àü´ÞÇϰԠµÇ°í, À̵頽ŰæÀý¼¼Æ÷´Â ´Ù½Ã ÀÌ·± ÀڱصéÀ» ¸ð¾Æ ½Ã°¢½Å°æÀ¯µÎ·Î º¸³»°Ô µÇ¸ç, ½Ã°¢½Å°æÀ¯µÎ¿¡¼­ºÎÅÍ ½Å°æÀü´ÞÀº ³ú±îÁö ÁøÇàÇÑ´Ù.
  
  ½Ã½Å°æÀ¯µÎ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accessory pathway
    µ¡Àüµµ·Î, ºÎÀüµµ·Î
  • alternative complement pathway
    ´ëüº¸Ã¼°æ·Î
  • biosynthetic pathway
    »ýÇÕ¼º°æ·Î
  • classic complement pathway
    ÀüÇüÀûº¸Ã¼°æ·Î
  • coagulation pathway
    ÀÀ°í°æ·Î
  • extrinsic pathway of coagulation
    ¿ÜÀμºÀÀ°í°æ·Î
  • intrinsic pathway of coagulation
    ³»ÀμºÀÀ°í°æ·Î
  • interneuronal signaling pathway
    ½Å°æ¼¼Æ÷°£½ÅÈ£Àü´Þ°æ·Î
  • internodal pathway
    °áÀý°£°æ·Î
  • motor pathway
    ¿îµ¿½Å°æ·Î
  • metabolic pathway
    ´ë»ç°æ·Î
  • pain pathway
    ÅëÁõÀü´Þ·Î
  • pathway
    °æ·Î, Åë·Î
  • subthalamopallidal pathway
    ½Ã»ó¹ØÃ¢¹éÇÙ·Î
  • sensory pathway
    °¨°¢·Î
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pathway
    °æ·Î, Åë·Î
  • accessory pathway
    µ¡Àüµµ·Î, ºÎÀüµµ·Î
  • biosynthetic pathway
    »ýÇÕ¼º°æ·Î, »ýÇÕ¼º°úÁ¤
  • metabolic pathway
    ´ë»ç°æ·Î
  • sensory pathway
    °¨°¢·Î
  • visual pathway
    ½Ã°¢°æ·Î
  • optic atrophy
    ½Ã°¢½Å°æÀ§Ãà
  • optic nerve atrophy
    (¢¡optic atrophy) ½Ã°¢½Å°æÀ§Ãà
  • optic chiasm
    ½Ã°¢±³Â÷
  • optic disc cupping
    ½Ã°¢½Å°æÀ¯µÎÆÐÀÓ, ½Ã°¢½Å°æÀ¯µÎÇÔ¸ô
  • optic disc
    ½Ã°¢½Å°æÀ¯µÎ
  • ischemic optic neuropathy
    ÇãÇ÷½Ã°¢½Å°æº´Áõ
  • optic neuritis
    ½Ã°¢½Å°æ¿°
  • optic nerve
    ½Ã°¢½Å°æ
  • retrobulbar optic neuritis
    ´«µÚ½Ã°¢½Å°æ¿°, ±¸ÈĽýŰ濰
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accessory pathway
    ºÎÀüµµ·Î
  • alternative complement pathway
    º¸Ã¼´ëü°æ·Î, µµ¿òü´ëü°æ·Î
  • biosynthetic pathway
    »ýÇÕ¼º°æ·Î, »ýÇÕ¼º°úÁ¤
  • classic complement pathway
    º¸Ã¼ÀüÇüÀû°æ·Î, µµ¿òüÀüÇüÀû°æ·Î
  • coagulation pathway
    ÀÀ°í°æ·Î
  • interneuronal signaling pathway
    ½Å°æ¼¼Æ÷°£½ÅÈ£Àü´Þ°æ·Î
  • internodal pathway
    ¸¶µð»çÀ̱æ
  • metabolic pathway
    ´ë»ç°æ·Î
  • motor pathway
    ¿îµ¿½Å°æ·Î
  • pathway
    °æ·Î, Åë·Î
  • pain pathway
    ÅëÁõÀü´Þ·Î
  • sensory pathway
    °¨°¢·Î
  • subthalamopallidal pathway
    ½Ã»ó¹ØÃ¢¹éÇÙ·Î, ½Ã»óÇÏ´ãⱸ·Î
  • transcellular pathway
    ¼¼Æ÷Ⱦ´Ü°æ·Î
  • visual pathway
    ½Ã°¢°æ·Î
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Embden-Meyerhof pathway
    ¿¥µ§-¸¶À̾î·ÎÇÁ °æ·Î(ÌèÖØ)
  • Lemniscus pathway
    ¸ð´ë°æ·Î(Ù¶ÓáÌèÖØ)
  • accessory pathway
    ºÎÀüµµ·Î.
  • acetate pathway
    ¾Æ¼¼Å×ÀÌÆ® ´ë»ç°æ·Î(¡­ÓÛÞóÌèÖØ).
  • acoustic pathway
    û°¢·Î
  • alternative pathway
    ±³´ë°æ·Î
  • alternative pathway
    º°µµ°æ·Î, ´ëü°æ·Î
  • glucuronic acid pathway
    ±Û·çÄí·Ð»ê°æ·Î.
  • glycolytic pathway
    ÇØ´ç°æ·Î
  • phosphogluconate oxidative pathway
    ±Û·çÄÜ»ê»êÈ­°æ·Î, ÀÎ´ç¿ø»êÈ­°æ·Î(ìÝÓØ ê«ß«ûùÌèÖØ).
  • proximal common pathway
    ±ÙÀ§°øÅë°æ·Î.
  • pyruvate pathway
    ÇÇ·çºê»ê¿°´ë»ç°æ·Î(¡­ß«ç¤ÓÛÞóÌèÖØ).
  • Devics disease=>optic neuromyelitis
    µ¥ºòº´
  • anterior ischemic optic neuropathy
    Àü¹æÇãÇ÷¼º ½Ã½Å°æº´Áõ(îñÛ°úÈúìàõãÊãêÌèÜ»ñø).
  • anterior ischemic optic neuropathy
    ¾ÕÇãÇ÷½Ã½Å°æº´Áõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • optic pathway
    ½Ã·Î.
  • optic pathway
    ½Ã½Å°æ·Î.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • optic nerve disk [optic papilla]
    ½Ã°¢½Å°æ¿ø¹Ý
  • retrobulbar optic neuritis ; axial optic neuritis
    ±¸ÈĽýŰ濰(Ϲý­ãÊãêÌèæú);Ã༺½Ã½Å°æ¿°(õîàõãÊãêÌèæú)
  • accessory pathway
    ºÎÀüµµ·Î.
  • acetate pathway
    ¾Æ¼¼Å×ÀÌÆ® ´ë»ç°æ·Î(¡­ÓÛÞóÌèÖØ).
  • acoustic pathway
    û°¢·Î
  • alternative pathway
    ±³´ë°æ·Î
  • alternative pathway
    º°µµ°æ·Î, ´ëü°æ·Î
  • biosynthetic pathway
    »ýÇÕ¼º°úÁ¤<°æ·Î>(¡­<ÌèÖØ>).
  • biosynthetic pathway
    »ýÇÕ¼º°æ·Î(¡­ÌèÖØ).
  • classic pathway
    ÀüÇüÀû °æ·Î
  • classical pathway
    °íÀü°æ·Î, °íÀüÀû°æ·Î (º¸Ã¼¹ÝÀÀÀÇ)
  • coagulation,intrinsic pathway
    ³»ºÎ °æ·Î(ҮݻÌèÖØ)
  • complement system, alternative pathway
    ´ëü°æ·Î(ÓÛôðÌèÖØ)
  • complement system, classic pathway
    ÀüÇüÀû °æ·Î(îðúþîÜÌèÖØ)
  • corticastriatal pathway
    ÇÇÁú¼±Á¶Ã¼°æ·Î(ù«òõàÊðÉô÷ÌèÖØ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Optic nerve disk [Optic papilla]
    ½Ã°¢½Å°æ¿ø¹Ý
    [¿¾ ¿ë¾î] ½Ã½Å°æ¿øÆÇ
  • Optic cavity
    ´«¼ÒÆ÷°ø°£
    [¿¾ ¿ë¾î] ¾È°­
  • Optic stalk
    ´«¼ÒÆ÷ÁÙ±â
    [¿¾ ¿ë¾î] ¾È°æ
  • Cavity of optic cup
    ´«¼úÀܰø°£
    [¿¾ ¿ë¾î] ¾È¹è°­
  • External plate of optic cup
    ´«¼úÀܹٱùÆÇ
    [¿¾ ¿ë¾î] ¾È¹è¿ÜÆÇ
  • Internal plate of optic cup
    ´«¼úÀܼӯÇ
    [¿¾ ¿ë¾î] ¾È¹è³»ÆÇ
  • Optic fovea
    ´«¿À¸ñ
    [¿¾ ¿ë¾î] ¾È¿Í
  • Optic mesenchyme
    ´«Áß°£¿±
    [¿¾ ¿ë¾î] ¾È°£¿±
  • Optic part of retina
    ¸Á¸·½Ã°¢ºÎºÐ
    [¿¾ ¿ë¾î] ¸Á¸·½ÃºÎ
  • Optic chiasm
    ½Ã°¢±³Â÷
    [¿¾ ¿ë¾î] ½Ã½Å°æ±³Â÷
  • Optic tract
    ½Ã°¢·Î
    [¿¾ ¿ë¾î] ½Ã»è
  • Optic tract branches
    ½Ã°¢·Î°¡Áö
    [¿¾ ¿ë¾î] ½Ã»èÁö
  • Optic radiation
    ½Ã°¢·ÎºÎê»ì
    [¿¾ ¿ë¾î] ½Ã¹æ»ç
  • Optic canal
    ½Ã°¢½Å°æ°ü
    [¿¾ ¿ë¾î] ½Ã½Å°æ°ü
  • Vascular ring of optic nerve
    ½Ã°¢½Å°æÇ÷°ü°í¸®
    [¿¾ ¿ë¾î] ½Ã½Å°æÇ÷°ü·û
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
  • optic pathway g.
    ½Ã½Å°æ·Î±³Á¾
    ãÊãêÌèÖØÎïðþ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alternative pathway
    ´ëü°æ·Î(ÓÛôðð¾ÌèÖØ)
  • aminoadipic pathway
    ¾Æ¹Ì³ë¾ÆµðÇÈ °æ·Î(ÌèÖØ)
  • amphibolic pathway
    ¾ç¸é¼º´ë»ç(ÕרüàõÓÛÞó)
  • arginine dihydrolase pathway
    ¾Æ¸£Áö´ÑµðÈ÷µå·Ñ·¹À̽º °æ·Î(ÌèÖØ)
  • biosynthetic pathway
    »ýÇÕ¼º°æ·Î(ßæùêà÷ÌèÖØ)
  • branched metabolic pathway
    ºÐÁö´ë»ç°æ·Î(ÝÂò«ÓÛÞóÌèÖØ)
  • central metabolic pathway
    ÁßÃß´ë»ç°æ·Î(ñéõÒÓÛÞóÌèÖØ)
  • C3 pathway
    C3 °æ·Î (ÌèÖØ)
  • C4 pathway
    C4 °æ·Î (ÌèÖØ)
  • cyclic metabolic pathway
    ȸ·Î ´ë»ç°æ·Î(üÞÖØÓÛÞóÌèÖØ)
  • DAP pathway
    "DAP °æ·Î(ÌèÖØ) (ÔÒ) diaminopimelate pathway,"
  • diaminopimelate pathway
    ÀÌ(ì£)¾Æ¹Ì³ëÇǸá»ê °æ·Î(ÌèÖØ)
  • direct oxidation pathway
    "Á÷Á¢»êÈ­°æ·Î(òÁïÈß«ûùÌèÖØ), (ÔÒ) hexose monophosphate shunt"
  • ED pathway
    ED °æ·Î(ÌèÖØ)
  • Embden-Meyerhof pathway
    ¿¥µ§-¸¶À̾îÈ£ÇÁ °æ·Î(ÌèÖØ)
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • optic pathway
    ½Ã½Å°æ·Î
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pathway
    °æ·Î
  • optic
    ´«ÀÇ, ½Ã°¢ÀÇ, °úÇÐÀÇ
  • optic atrophy
    ½Ã½Å°æÀ§Ãà
  • optic chiasma
    ½Ã½Å°æ±³Â÷
  • optic commissure
    ½Ã½Å°æ±³·Ã
  • optic disc
    ½Ã½Å°æÀ¯µÎ
  • optic foramen
    ½Ã½Å°æ°ø
  • optic nerve
    ½Ã½Å°æ
  • optic nerve atrophy
    ½Ã½Å°æÀ§Ãà
  • optic neuritis
    ½Ã½Å°æ¿°
  • optic recess
    ½Ã±³Â÷ÇÔ¿ä
  • optic tract
    ½Ã»è
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
EM Pathway Embden Meyerhof Pathway
AP accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p...
ACP accessory conduction pathway; acid phosphatase; acyl carrier protein; American College of Pathologis...
AERPAP antegrade effective refractory period accessory pathway
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AP accessory pathway
ACP Alternative complement pathway
AP Alternative pathway
CP Classical pathway
EPI Extrinsic Pathway Inhibitor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cavity of optic cup
    ´« ¼úÀÜ °ø°£
  • coloboma of optic disc
    ½Ã½Å°æ À¯µÎ °á¼Õ
  • communicating branch with optic ganglion
    ±Í½Å °æÀý°úÀÇ ±³Åë °¡Áö, ÀÌ ½Å°æÀý°úÀÇ ±³ÅëÁö
  • excavation of optic nerve head
    ½Ã½Å°æ À¯µÎ ÇÔ¸ô
  • fiber optic
    ±¤¼¶À¯
    ÀÚ½ÅÀÇ ±æÀÌ ¹æÇâÀ¸·Î ºûÀ̳ª ¹æ»ç ¿¡³ÊÁöÀÇ Àü´ÞÀÌ °¡´ÉÇÑ Åõ¸íÇÑ ¼¶À¯°¡´Ú ȤÀº ´Ù¹ß
  • fiber optic delivery system
    ±¤ ¼¶À¯ Àü´Þ°è
  • lacunar optic atrophy
    ÇØ¸é ½Ã½Å°æ À§Ãà
  • lebers hereditary optic neuropathy
    ·¹¹ö¾¾ ¼±Ãµ¼º ½Ã½Å°æº´Áõ
  • neuro-optic myelitis
    ½Å°æ¼º ½Ã°¢¼º ô¼ö¿°
  • optic
    ´«ÀÇ, ½Ã°¢ÀÇ, ±¤ÇÐÀÇ, ¾ÈÀÇ
    ´«ÀÇ ¶Ç´Â ´«¿¡ °üÇÑ.
  • optic aphasia
    ½Ã°¢¼º ½Ç¾î, ½Ã°¢¼º ½Ç¾îÁõ
    ¾ð¾î ÁßÃß¿Í ½Ã°¢ ÁßÃß°£ÀÇ ¿¬¶ô Àå¾Ö¿¡ ÀÇÇØ ÀϾ¸ç º¸ÀÌ´Â ¹°Ã¼ÀÇ ¸íĪÀ» ¸»ÇÏÁö ¸øÇÏ´Â ½Ç¾îÁõ.
  • optic cavitation
    ±¤ÇÐ °øµ¿È­
  • optic disc coloboma
    ½Ã½Å°æ À¯µÎ °á¼ÕÁõ
  • optic keratoplasty
    ½Ã·Â º¸Ãæ °¢¸· À̽ļú
    °¢¸· ȥŹ¿¡ ÀÇÇÏ¿© ½Ã·ÂÀÌ ÀúÇϵǾúÀ» °æ¿ì, ½Ã·ÂÀ» ³»±â À§ÇÏ¿© ÇàÇÏ´Â °¢¸· À̽Ä.
  • optic lobe
    »ç±¸Ã¼
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
alternative oxidase pathway Pathway of mitochondrial electron transport in higher plants, particularly in fruits and seeds, that does not involve cytochrome oxidase and thus is resistant to cyanide.
(18 Nov 1997)
alternative pathway See: complement activation.
(18 Nov 1997)
anabolic pathway <biochemistry> A reaction or series of reactions in a metabolic pathway that synthesise complex molecules from simpler ones, usually requiring the input of energy.
Compare: catabolic pathway.
(09 Oct 1997)
auditory pathway Neural paths and connections within the central nervous system, beginning at the organ of Corti's hair cells, continuing along the eighth nerve, and terminating at the auditory cortex.
(05 Mar 2000)
GABA pathway The pathway that ultimately converts 4-aminobutyrate to succinate; succinate is then converted to alpha-ketoglutarate, via the tricarboxylic acid cycle, which is then acted upon by glutamate dehydrogenase; glutamate is then decarboxylated to reform 4-aminobutyrate; an important pathway for those cells which make this neuroactive molecule.
Synonym: GABA pathway.
(05 Mar 2000)
Palade pathway <cell biology> The routing of proteins from the site of their synthesis to the final cellular or secreted position. Several different pathways are known and others suspected. Glycosylation of the proteins may provide specific address labels for the proteins.
(18 Nov 1997)
catabolic pathway <biochemistry> A series of reactions in a metabolic pathway that break down complex compounds into simpler ones, usually releasing energy in the process.
Compare: anabolic pathway.
(16 Mar 1998)
pathway 1. A collection of axons establishing a conduction route for nerve impulses from one group of nerve cells to another group or to an effector organ composed of muscle or gland cells.
2. Any sequence of chemical reactions leading from one compound to another; if taking place in living tissue, usually referred to as a biochemical pathway.
(05 Mar 2000)
visual pathway Neural paths and connections within the central nervous system, beginning with the retina and terminating in the occipital cortex.
(05 Mar 2000)
pentose phosphate pathway <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate.
Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses.
In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection.
Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose.
(18 Nov 1997)
perforant pathway A pathway of fibres originating in the lateral part of the entorhinal area, perforating the subiculum of the hippocampus, and running into the stratum moleculare of the hippocampus, where these fibres synapse with others that go to the dentate gyrus. It is also called the perforating fasciculus.
(12 Dec 1998)
mercapturic acid pathway A glutathione-dependent pathway for the detoxification of a number of compounds, including arene oxides; an S-substituted glutathione is formed and ultimately converted to a mercapturic acid (an S-substituted N-acetylated l-cysteine), which is excreted; the leukotrienes are believed to be degraded through this pathway.
(05 Mar 2000)
RMP pathway <biochemistry> Ribulose monophosphate pathway, also called allulose phosphate pathway. A metabolic pathway used by methylotropic bacteria for the conversion of formaldehyde to hexose sugars etc. In the first stage ribulose 5 phosphate is condensed with HCHO.
(23 Aug 1998)
phosphogluconate pathway <biochemistry> This oxidative pathway starts with glucose-6-phosphate andeventually results in the creation of pentose phosphates and NADPH.
(09 Oct 1997)
complement pathway, alternative The complement activation sequence initiated by the activation of complement factor c3, which is triggered by the interaction of microbial polysaccharides and properdin without participation of an antigen-antibody reaction.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pathway
    Á¼Àº±æ;¿À¼Ö±æ
  • optic
    ´«ÀÇ;½Ã°¢ÀÇ
  • optic
    ´«;±¤ÇÐ;optical a;´«ÀÇ;½Ã·ÂÀÇ(À» µ½´Â);±¤ÇÐ(»ó)ÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á